Ginseng i.e Ashwagandha is a type of Herb and its properties as follows :-
Active_Compound Dietry_product Type Temperatute Ref_Temp Url_Temp
Ginseng i.e Ashwagandha is a type of Herb and its properties as follows :-
Active_Compound Dietry_product Qty Ref Url Qty/day (Min-Max) Ref Url T_half (Min-Max) Peak value (Min-Max)
Ginseng i.e Ashwagandha is a type of Herb and its properties as follows :-
Active_Compound Enhencer Effect Reference Url
Ginseng i.e Ashwagandha is a type of Herb and its properties as follows :-
Active_Compound Inhibitor Effect Ref Url

Pathway of Dietry Product


​   ► Medicine for Ginseng i.e Ashwagandha as follows :-
Cisplatin with same compound,

  ►  Pathway with its reference as follows :-
  • Ginsenosides, Panaxosides have anticancer effect --- (Chen, Yan et al. )

  •   ►  URL --
  • https://cancerci.biomedcentral.com/articles/10.1186/1475-2867-13-24
  • Dietry Substance Interactions


    ​   ► Ginseng i.e Ashwagandha interact with medicines having some effect as follows :-
    'Not Found'

    ContraIndication Dietry Substance


    ​   ► Ginseng i.e Ashwagandha Contraindicate with medicines as follows :-
    BECLOMETASONE Interact when taken together , PREDNISOLONE Interact when taken together, PREDNISONE Interact when taken together, APOMORPHINE Mania, headache, tremor, and insomnia, reduced blood glucose, HbA1c, plasma cholesterol, triglyceride, LDL, and NEFA; elevated HDL, LH, FSH; altered BP,

      ►  Reference :-
  • Eldelberg, D. The New Age of nutritional and herbal remedies. New Zealand
  • Posadzki, P., Watson, L., & Ernst, E. (2012). Herb-drug interactions: an overview of systematic reviews. British Journal Of Clinical Pharmacology, no-no. http://dx.doi.org/10.1111/j.1365-2125.2012.04350.x

  •   ►  URL :-
  • https://books.google.co.in/books?id=WZhj8EO9N3sC&pg=PA49&lpg=PA49&dq=The+New+Age+of+nutritional+and+herbal+remedies.++book&source=bl&ots=UVld-vNZL0&sig=5KwkKUUvW45p0TkfVUCtMZxnbow&hl=en&sa=X&ved=0ahUKEwiajLCNocrOAhVMto8KHfD2D-4Q6AEIMDAE#v=onepage&q=The%20
  • http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04350.x/full